# Domain Expert Assessment: MCT1 Disruption Mechanisms in Neurodegeneration
## Preamble
The Lee et al. (2012) framework established that oligodendroglial MCT1 is non-negotiable for axonal survival, but the downstream cascade remains one of the most consequential unknowns in metabolically driven neurodegeneration. Your Theorist's SIRT3 hypothesis is mechanistically sophisticated but—per the Skeptic's critique—has significant translational liabilities. Let me offer a frank assessment.
---
## 1. Top Translational Hypotheses
### Rank 1: Neuronal NAD+ Depletion via NAMPT Dysregulation → Sirtuin Insufficiency
**Mechanistic basis**: MCT1 disruption reduces lactate flux into axons, impairing the neuronal lactate-to-pyruvate conversion that normally supports NADH→NAD⁺ cycling during high-activity periods. When axonal NAD⁺ falls, NAMPT—the rate-limiting step in the NAD⁺ salvage pathway—faces increased demand. Under chronic stress (Aβ accumulation, neuroinflammation), NAMPT activity itself becomes compromised, creating a feed-forward NAD⁺ deficit that impairs sirtuin activity broadly.
**Current clinical evidence**: NAD⁺ precursor supplementation is among the most active translational pipelines in neurodegeneration. Nicotinamide riboside (NR, Niagen®) and nicotinamide mononucleotide (NMN) are in multiple Phase I/II trials for neurodegenerative conditions (NCT03057573, NCT04462493). No direct Alzheimer's efficacy data yet, but mechanistic rationale is strong.
**Safety considerations**: NR and NMN have favorable safety profiles at doses up to 1–2 g/day in human trials. The primary concern for your hypothesis is *specificity*—NAD⁺ precursors will affect all tissues and all sirtuins, not just axonal SIRT3. Off-target effects on systemic immunity and tumor surveillance require monitoring.
**Patient population fit**: Early-to-mild Alzheimer's (prodromal or MCI) is ideal because axonal NAD⁺ depletion is likely upstream of significant tau pathology. Patients with confirmed white matter abnormalities on DTI-MRI or elevated neurofilament light chain (NfL) would represent a enrichment strategy targeting the subpopulation most likely to have oligodendroglial metabolic contribution to their neurodegeneration